摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3,5,7-Trimethyl-1-(oxan-2-ylmethoxy)-6-phenylpyrrolo[3,4-d]pyridazin-4-one

中文名称
——
中文别名
——
英文名称
3,5,7-Trimethyl-1-(oxan-2-ylmethoxy)-6-phenylpyrrolo[3,4-d]pyridazin-4-one
英文别名
——
3,5,7-Trimethyl-1-(oxan-2-ylmethoxy)-6-phenylpyrrolo[3,4-d]pyridazin-4-one化学式
CAS
——
化学式
C21H25N3O3
mdl
——
分子量
367.448
InChiKey
XNMSDAOXPBMREX-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.2
  • 重原子数:
    27
  • 可旋转键数:
    4
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.43
  • 拓扑面积:
    56.1
  • 氢给体数:
    0
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    描述:
    2-(bromomethyl)tetrahydro-2H-pyran3,5,7-trimethyl-6-phenyl-2H-pyrrolo[3,4-d]pyridazine-1,4-dionepotassium carbonate 作用下, 以 乙腈 为溶剂, 反应 10.0h, 以33%的产率得到3,5,7-Trimethyl-1-(oxan-2-ylmethoxy)-6-phenylpyrrolo[3,4-d]pyridazin-4-one
    参考文献:
    名称:
    New derivatives of pyrrolo[3,4-d]pyridazinone and their anticancer effects
    摘要:
    Eighteen new derivatives of pyrrolo[3,4-d]pyridazinone modified at the pyrrole and pyridazine rings were synthesized and 12 of them were evaluated in vitro through anticancer screenings. The structures of new compounds were confirmed by elemental analysis and spectral data (IR, 1H NMR). None of the eight compounds assayed blocked the cell cycle regulating CDK1/cyclin B kinase, whereas two of the six compounds tested were active in anticancer screening at the cell experiments at a concentration of > or = 10(-5) M/l.
    DOI:
    10.1016/j.farmac.2004.03.002
点击查看最新优质反应信息

文献信息

  • New derivatives of pyrrolo[3,4-d]pyridazinone and their anticancer effects
    作者:Wiesław Malinka、Aleksandra Redzicka、Olivier Lozach
    DOI:10.1016/j.farmac.2004.03.002
    日期:2004.6
    Eighteen new derivatives of pyrrolo[3,4-d]pyridazinone modified at the pyrrole and pyridazine rings were synthesized and 12 of them were evaluated in vitro through anticancer screenings. The structures of new compounds were confirmed by elemental analysis and spectral data (IR, 1H NMR). None of the eight compounds assayed blocked the cell cycle regulating CDK1/cyclin B kinase, whereas two of the six compounds tested were active in anticancer screening at the cell experiments at a concentration of > or = 10(-5) M/l.
查看更多